Drug
Ivabradine 5mg Tab
Ivabradine 5mg Tab is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
unknown133%
completed133%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock
NCT06742164
completedphase_2
Effect of Ivabradine on Microcirculation and Cardiac Output in Septic Shock Patients
NCT05141071
unknownphase_2
Early Administration of Ivabradine in Children With Heart Failure
NCT04405804
Clinical Trials (3)
Showing 3 of 3 trials
NCT06742164Not Applicable
Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock
NCT05141071Phase 2
Effect of Ivabradine on Microcirculation and Cardiac Output in Septic Shock Patients
NCT04405804Phase 2
Early Administration of Ivabradine in Children With Heart Failure
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3